Dementia

Questions discussed in this category

What factors might drive decisions for different SSRIs and/or doses?

What would be your approach to the consideration of the use of antiamyloid monoclonal antibodies for nonamnestic Alzheimer's disease with a positive biomarker for brain amyloid pathology?

E.g., primary progressive aphasia

2 Answers available

Are there scenarios in which you would advise using benzodiazepines for the treatment of hyperactive delirium?

1 Answer available

How do you approach evaluating sudden mental status changes in telepsychiatry patients, particularly older adults, when medical causes such as infection or metabolic disturbance may be contributing factors?

What red flags prompt you to recommend urgent in-person evaluation? Are there particular strategies or screening questions you have found helpful to d...

1 Answer available

Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?

Seminer et al., PMID 40193122

1 Answer available

How do you approach balancing the treatment of urinary incontinence with anticholinergic medications with the use of cholinesterase inhibitors in dementia?

1 Answer available

How do you approach individualizing A1c goals in patients with dementia?

2 Answers available

How do you select between antipsychotics in the treatment of delirium refractory to nonpharmacological management in hospitalized older adults with dementia?

From a geriatrics harm-reduction standpoint, can we recommend any particulars regarding dosing or selection of therapies when used as a last resort?

1 Answer available

How do you treat agitation in progressive supranuclear palsy?

Would you consider benzodiazepines for agitation in progressive supranuclear palsy? What other treatment strategies would you consider?

1 Answer available

What are your preferred strategies for managing sundowning in patients with moderate Alzheimer’s disease?

2 Answers available

Do you recommend life long aspirin 81 mg daily for non-specific T2 white matter hyper-intensities on MRI brain?

7 Answers available

Papers discussed in this category

Front Neurol, 2021 Jul 01

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Semin Neurol, 2022 Apr

Medication Management of Neuropsychiatric Symptoms in Neurological Conditions: A Dimensional Transdiagnostic Approach.

The American journal of psychiatry, 2016-05-01

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

The American journal of psychiatry, 2016-05-01

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.

JAMA, 2014 Feb 19

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Frontiers in aging neuroscience, 2023 Mar 03

Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis.

Journal of Alzheimer's disease : JAD, 2020

The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).

Journal of the American Geriatrics Society, 2025 Apr 28

Treatment of Inappropriate Sexual Behavior in Persons With Dementia: A Systematic Review.

Journal of the American Geriatrics Society, 2016 Mar 23

Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis.

The Cochrane database of systematic reviews, 2018 Jun 18

Antipsychotics for treatment of delirium in hospitalised non-ICU patients.

Dementia

Questions discussed in this category

Papers discussed in this category

Related Topics